Page 106 - AI for Good-Innovate for Impact

AI for Good-Innovate for Impact

22�4� Sequence diagram

22�5� References

[1] “Global TB Overview.” Accessed: May 11, 2024. [Online]. Available: https:// www .cdc
.gov/ globalhivtb/ who -we -are/ about -us/ globaltb/ globaltb .html

[2] N. Zaporojan, R. A. Negrean, R. Hodișan, C. Zaporojan, A. Csep, and D. C. Zaha, “Evolution
of Laboratory Diagnosis of Tuberculosis,” Clinics and Practice 2024, Vol. 14, Pages 388-416,
vol. 14, no. 2, pp. 388–416, Feb. 2024, doi: 10.3390/CLINPRACT14020030.

[3] A. D. S. R. Moreira et al., “Liquid vs Solid Culture Medium to Evaluate Proportion and
Time to Change in Management of Suspects of Tuberculosis—A Pragmatic Randomized Trial
in Secondary and Tertiary Health Care Units in Brazil,” PLoS One, vol. 10, no. 6, p. e0127588,
Jun. 2015, doi: 10.1371/JOURNAL.PONE.0127588.

[4] E. Scholar, “Diseases caused by atypical mycobacterium species,” xPharm: The
Comprehensive Pharmacology Reference, pp. 1–4, 2007, doi: 10.1016/B978-008055232-
3.60892-X.

[5] M. L. Bayot, T. M. Mirza, and S. Sharma, “Acid Fast Bacteria,” StatPearls, Aug. 2023,
Accessed: May 11, 2024. [Online]. Available: https:// www .ncbi .nlm .nih .gov/ books/ NBK537121/
[6] E. J. Hwang, W. G. Jeong, P.-M. David, M. Arentz, M. Ruhwald, and S. H. Yoon, “AI
for Detection of Tuberculosis: Implications for Global Health,” https:// doi .org/ 10 .1148/ ryai
.230327, vol. 6, no. 2, Jan. 2024, doi: 10.1148/RYAI.230327.

[7] A. Kochi, “The global tuberculosis situation and the new control strategy of the World
Health Organization,” Tubercle, vol. 72, no. 1, pp. 1–6, 1991, doi: 10.1016/0041-3879(91)90017-
m.

90